메뉴 건너뛰기




Volumn 13, Issue 9, 2009, Pages 1105-1120

Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: Could their inhibition be an effective therapeutic approach?

Author keywords

Gynecological malignancies; Matrix metalloproteinases; MMPs; TIMPs; Tissue inhibitors of MMPs

Indexed keywords

BATIMASTAT; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CGS 27023A; COLLAGENASE 3; GELATINASE A; GELATINASE B; HYDROXAMIC ACID DERIVATIVE; INTERSTITIAL COLLAGENASE; MARIMASTAT; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; PRINOMASTAT; REBIMASTAT; STROMELYSIN 2; STROMELYSIN 3; TANOMASTAT; TETRACYCLINE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNINDEXED DRUG;

EID: 68549121084     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903136767     Document Type: Review
Times cited : (11)

References (162)
  • 2
    • 0036512208 scopus 로고    scopus 로고
    • New functions for the matrix metalloproteinases in cancer progression
    • Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2(3):161-174 (Pubitemid 37328786)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.3 , pp. 161-174
    • Egeblad, M.1    Werb, Z.2
  • 3
    • 0026425631 scopus 로고
    • Tumor invasion and metastasis: An imbalance of positive and negative regulation
    • Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;51(18 Suppl):5054s-9s
    • (1991) Cancer Res , vol.51 , Issue.18 SUPPL.
    • Liotta, L.A.1    Stetler-Stevenson, W.G.2
  • 4
    • 0030806173 scopus 로고    scopus 로고
    • Changing views of the role of matrix metalloproteinases in metastasis
    • Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89(17):1260-1270 (Pubitemid 27371946)
    • (1997) Journal of the National Cancer Institute , vol.89 , Issue.17 , pp. 1260-1270
    • Chambers, A.F.1    Matrisian, L.M.2
  • 5
    • 0029977810 scopus 로고    scopus 로고
    • MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis
    • Kinoh H, Sato H, Tsunezuka Y, et al. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996;109(Pt 5):953-959 (Pubitemid 26168248)
    • (1996) Journal of Cell Science , vol.109 , Issue.5 , pp. 953-959
    • Kinoh, H.1    Sato, H.2    Tsunezuka, Y.3    Takino, T.4    Kawashima, A.5    Okada, Y.6    Seiki, M.7
  • 6
    • 0028907318 scopus 로고
    • Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
    • Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270(10):5331-5338
    • (1995) J Biol Chem , vol.270 , Issue.10 , pp. 5331-5338
    • Strongin, A.Y.1    Collier, I.2    Bannikov, G.3
  • 7
    • 0030037395 scopus 로고    scopus 로고
    • Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
    • DOI 10.1074/jbc.271.29.17124
    • Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271(29):17124-17131 (Pubitemid 26244262)
    • (1996) Journal of Biological Chemistry , vol.271 , Issue.29 , pp. 17124-17131
    • Knauper, V.1    Will, H.2    Lopez-Otin, C.3    Smith, B.4    Atkinson, S.J.5    Stanton, H.6    Hembry, R.M.7    Murphy, G.8
  • 9
    • 0032850365 scopus 로고    scopus 로고
    • Matrix metalloproteinases in tumour invasion and metastasis
    • DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2- C
    • Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189(3):300-308 (Pubitemid 29489213)
    • (1999) Journal of Pathology , vol.189 , Issue.3 , pp. 300-308
    • Curran, S.1    Murray, G.I.2
  • 10
    • 0033618337 scopus 로고    scopus 로고
    • Matrix metalloproteinases
    • Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274(31):21491-21494
    • (1999) J Biol Chem , vol.274 , Issue.31 , pp. 21491-21494
    • Nagase, H.1    Woessner Jr., J.F.2
  • 11
    • 0031025218 scopus 로고    scopus 로고
    • Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
    • DOI 10.1074/jbc.272.4.2446
    • Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272(4):2446-2451 (Pubitemid 27058534)
    • (1997) Journal of Biological Chemistry , vol.272 , Issue.4 , pp. 2446-2451
    • Ohuchi, E.1    Imai, K.2    Fujii, Y.3    Sato, H.4    Seiki, M.5    Okada, Y.6
  • 12
    • 0033605561 scopus 로고    scopus 로고
    • Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
    • DOI 10.1074/jbc.274.13.8925
    • Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 1999;274(13):8925-8932 (Pubitemid 29164694)
    • (1999) Journal of Biological Chemistry , vol.274 , Issue.13 , pp. 8925-8932
    • Pei, D.1
  • 13
    • 0030019731 scopus 로고    scopus 로고
    • Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
    • Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996;119(2):209-215 (Pubitemid 26063238)
    • (1996) Journal of Biochemistry , vol.119 , Issue.2 , pp. 209-215
    • Sato, H.1    Seiki, M.2
  • 14
    • 0037498559 scopus 로고    scopus 로고
    • Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer
    • DOI 10.1016/S0090-8258(03)00077-5
    • Tunuguntla R, Ripley D, Sang QX, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 2003;89(3):453-459 (Pubitemid 36687792)
    • (2003) Gynecologic Oncology , vol.89 , Issue.3 , pp. 453-459
    • Tunuguntla, R.1    Ripley, D.2    Sang, Q.-X.A.3    Chegini, N.4
  • 15
    • 0031671855 scopus 로고    scopus 로고
    • Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
    • DOI 10.1016/S0955-0674(98)80035-5
    • Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10(5):602-608 (Pubitemid 28477018)
    • (1998) Current Opinion in Cell Biology , vol.10 , Issue.5 , pp. 602-608
    • Shapiro, S.D.1
  • 16
    • 0036716282 scopus 로고    scopus 로고
    • Strategies for MMP inhibition in cancer: Innovations for the post-trial era
    • DOI 10.1038/nrc884
    • Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2(9):657-672 (Pubitemid 37328917)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.9 , pp. 657-672
    • Overall, C.M.1    Lopez-Otin, C.2
  • 17
    • 0022382006 scopus 로고
    • Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
    • DOI 10.1038/318066a0
    • Docherty AJ, Lyons A, Smith BJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318(6041):66-69 (Pubitemid 16230337)
    • (1985) Nature , vol.318 , Issue.6041 , pp. 66-69
    • Docherty, A.J.P.1    Lyons, A.2    Smith, B.J.3
  • 19
    • 0029806813 scopus 로고    scopus 로고
    • Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
    • DOI 10.1074/jbc.271.48.30375
    • Greene J, Wang M, Liu YE, et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271(48):30375-30380 (Pubitemid 26404039)
    • (1996) Journal of Biological Chemistry , vol.271 , Issue.48 , pp. 30375-30380
    • Greene, J.1    Wang, M.2    Liu, Y.E.3    Raymond, L.A.4    Rosen, C.5    Shi, Y.E.6
  • 20
    • 0029019867 scopus 로고
    • The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
    • Erratum in: J Biol Chem 1996;271(5):2874
    • Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 1995;270(24):14313-8. Erratum in: J Biol Chem 1996;271(5):2874
    • (1995) J Biol Chem , vol.270 , Issue.24 , pp. 14313-14318
    • Apte, S.S.1    Olsen, B.R.2    Murphy, G.3
  • 21
    • 0031000957 scopus 로고    scopus 로고
    • Activation of progelatinase a and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase
    • Kolkenbrock H, Hecker-Kia A, Orgel D, et al. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem 1997;378(2):71-76 (Pubitemid 27166039)
    • (1997) Biological Chemistry , vol.378 , Issue.2 , pp. 71-76
    • Kolkenbrock, H.1    Hecker-Kia, A.2    Orgel, D.3    Ulbrich, N.4    Will, H.5
  • 24
    • 0031467314 scopus 로고    scopus 로고
    • Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
    • DOI 10.1074/jbc.272.50.31730
    • Suzuki M, Raab G, Moses MA, et al. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997;272(50):31730-31737 (Pubitemid 28013322)
    • (1997) Journal of Biological Chemistry , vol.272 , Issue.50 , pp. 31730-31737
    • Suzuki, M.1    Raab, G.2    Moses, M.A.3    Fernandez, C.A.4    Klagsbrun, M.5
  • 25
    • 0035500490 scopus 로고    scopus 로고
    • The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis
    • DOI 10.1016/S0962-8924(01)02122-5, PII S0962892401021225
    • Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;11(11):S37-43 (Pubitemid 33001442)
    • (2001) Trends in Cell Biology , vol.11 , Issue.11
    • Chang, C.1    Werb, Z.2
  • 26
    • 0033380154 scopus 로고    scopus 로고
    • Matrix metalloproteinases in repair
    • Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7(6):423-432
    • (1999) Wound Repair Regen , vol.7 , Issue.6 , pp. 423-432
    • Parks, W.C.1
  • 28
    • 0028049576 scopus 로고
    • Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
    • Rodgers WH, Matrisian LM, Giudice LC, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94(3):946-953
    • (1994) J Clin Invest , vol.94 , Issue.3 , pp. 946-953
    • Rodgers, W.H.1    Matrisian, L.M.2    Giudice, L.C.3
  • 29
    • 0027247917 scopus 로고
    • Secretion of matrix metalloproteinases by human endometrial cells in vitro
    • Martelli M, Campana A, Bischof P. Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil 1993;98(1):67-76 (Pubitemid 23204747)
    • (1993) Journal of Reproduction and Fertility , vol.98 , Issue.1 , pp. 67-76
    • Martelli, M.1    Campana, A.2    Bischof, P.3
  • 30
    • 0026896029 scopus 로고
    • The matrix-degrading metalloproteinases
    • Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14(7):455-463
    • (1992) Bioessays , vol.14 , Issue.7 , pp. 455-463
    • Matrisian, L.M.1
  • 31
    • 0028141232 scopus 로고
    • Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation
    • Hampton AL, Salamonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 1994;141(1):R1-3
    • (1994) J Endocrinol , vol.141 , Issue.1
    • Hampton, A.L.1    Salamonsen, L.A.2
  • 33
    • 33645312651 scopus 로고    scopus 로고
    • Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: A clinical-pathological correlation study
    • Graesslin O, Cortez A, Fauvet R, et al. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol 2006;17(4):637-645
    • (2006) Ann Oncol , vol.17 , Issue.4 , pp. 637-645
    • Graesslin, O.1    Cortez, A.2    Fauvet, R.3
  • 34
    • 4444276289 scopus 로고    scopus 로고
    • Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer
    • DOI 10.1016/j.ygyno.2004.05.024, PII S0090825804003348
    • Pilka R, Norata GD, Domanski H, et al. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. Gynecol Oncol 2004;94(3):661-670 (Pubitemid 39194458)
    • (2004) Gynecologic Oncology , vol.94 , Issue.3 , pp. 661-670
    • Pilka, R.1    Norata, G.D.2    Domanski, H.3    Andersson, C.4    Hansson, S.5    Eriksson, P.6    Casslen, B.7
  • 36
    • 0034502797 scopus 로고    scopus 로고
    • Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium: Enhanced expression by endometrial adenocarcinomas is associated with low differentiation
    • Maatta M, Soini Y, Liakka A, et al. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000;114(3):402-411 (Pubitemid 33049676)
    • (2000) American Journal of Clinical Pathology , vol.114 , Issue.3 , pp. 402-411
    • Maatta, M.1    Soini, Y.2    Liakka, A.3    Autio-Harmainen, H.4
  • 37
    • 5044250714 scopus 로고    scopus 로고
    • Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26
    • A descriptive article concerning TIMP-4 and MMP-26
    • Pilka R, Domanski H, Hansson S, et al. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 2004;10(9):641-650 •• A descriptive article concerning TIMP-4 and MMP-26.
    • (2004) Mol Hum Reprod , vol.10 , Issue.9 , pp. 641-650
    • Pilka, R.1    Domanski, H.2    Hansson, S.3
  • 38
    • 0041334206 scopus 로고    scopus 로고
    • Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding
    • DOI 10.1016/S0015-0282(03)00797-0
    • Chegini N, Rhoton-Vlasak A, Williams RS. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril 2003;80(3):564-570 (Pubitemid 37102867)
    • (2003) Fertility and Sterility , vol.80 , Issue.3 , pp. 564-570
    • Chegini, N.1    Rhoton-Vlasak, A.2    Williams, R.S.3
  • 39
    • 33748673747 scopus 로고    scopus 로고
    • Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition
    • DOI 10.1055/s-2006-948552
    • Curry TE Jr, Smith MF. Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Semin Reprod Med 2006;24(4):228-241 (Pubitemid 44387527)
    • (2006) Seminars in Reproductive Medicine , vol.24 , Issue.4 , pp. 228-241
    • Curry Jr., T.E.1    Smith, M.F.2
  • 41
    • 0041352075 scopus 로고    scopus 로고
    • The matrix metalloproteinase system: Changes, regulation, and impact throughout the ovarian and uterine reproductive cycle
    • Probably the most well-written review article that can currently be found on the role of MMPs in the physiological processes involved in the reproductive cycle
    • Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24(4):428-465 •• Probably the most well-written review article that can currently be found on the role of MMPs in the physiological processes involved in the reproductive cycle.
    • (2003) Endocr Rev , vol.24 , Issue.4 , pp. 428-465
    • Curry Jr., T.E.1    Osteen, K.G.2
  • 42
    • 0035032124 scopus 로고    scopus 로고
    • Cyclic changes in the matrix metalloproteinase system in the ovary and uterus
    • Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001;64(5):1285-1296
    • (2001) Biol Reprod , vol.64 , Issue.5 , pp. 1285-1296
    • Curry Jr., T.E.1    Osteen, K.G.2
  • 43
    • 0033041733 scopus 로고    scopus 로고
    • Changes in the cervical extracellular matrix during pregnancy and parturition
    • Winkler M, Rath W. Changes in the cervical extracellular matrix during pregnancy and parturition. J Perinat Med 1999;27(1):45-60 (Pubitemid 29145889)
    • (1999) Journal of Perinatal Medicine , vol.27 , Issue.1 , pp. 45-60
    • Winkler, M.1    Rath, W.2
  • 44
    • 54349116550 scopus 로고    scopus 로고
    • Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
    • Published online 30 September 2008, doi:10.1186/1477-7827-6-45
    • Becher N, Hein M, Uldbjerg N, Danielsen CC. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP. Reprod Biol Endocrinol 2008;6:45. Published online 30 September 2008, doi:10.1186/1477-7827-6-45
    • (2008) Reprod Biol Endocrinol , vol.6 , pp. 45
    • Becher, N.1    Hein, M.2    Uldbjerg, N.3    Danielsen, C.C.4
  • 45
    • 0037693895 scopus 로고    scopus 로고
    • Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
    • DOI 10.1161/01.RES.0000070112.80711.3D
    • Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92(8):827-839 (Pubitemid 36542523)
    • (2003) Circulation Research , vol.92 , Issue.8 , pp. 827-839
    • Visse, R.1    Nagase, H.2
  • 46
    • 0032821995 scopus 로고    scopus 로고
    • Extracellular matrix degradation by metalloproteinases and central nervous system diseases
    • Lukes A, Mun-Bryce S, Lukes M, et al. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 1999;19(3):267-284 (Pubitemid 29418895)
    • (1999) Molecular Neurobiology , vol.19 , Issue.3 , pp. 267-284
    • Lukes, A.1    Mun-Bryce, S.2    Lukes, M.3    Rosenberg, G.A.4
  • 47
    • 0033989425 scopus 로고    scopus 로고
    • The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
    • Rooprai HK, Rucklidge GJ, Panou C, et al. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 2000;82(1):52-55 (Pubitemid 30008958)
    • (2000) British Journal of Cancer , vol.82 , Issue.1 , pp. 52-55
    • Rooprai, H.K.1    Rucklidge, G.J.2    Panou, C.3    Pilkington, G.J.4
  • 48
    • 0842332135 scopus 로고    scopus 로고
    • Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression
    • Torng PL, Mao TL, Chan WY, et al. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Gynecol Oncol 2004;92(2):559-567
    • (2004) Gynecol Oncol , vol.92 , Issue.2 , pp. 559-567
    • Torng, P.L.1    Mao, T.L.2    Chan, W.Y.3
  • 49
    • 0034488852 scopus 로고    scopus 로고
    • Interstitial collagenases as markers of tumor progression
    • Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6(12):4823-4830 (Pubitemid 32110426)
    • (2000) Clinical Cancer Research , vol.6 , Issue.12 , pp. 4823-4830
    • Brinckerhoff, C.E.1    Rutter, J.L.2    Benbow, U.3
  • 50
    • 0031724948 scopus 로고    scopus 로고
    • Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells
    • DOI 10.1210/jc.83.5.1721
    • Huang HY, Wen Y, Irwin JC, et al. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998;83(5):1721-1729 (Pubitemid 28501048)
    • (1998) Journal of Clinical Endocrinology and Metabolism , vol.83 , Issue.5 , pp. 1721-1729
    • Huang, H.-Y.1    Wen, Y.2    Irwin, J.C.3    Kruessel, J.S.4    Soong, Y.-K.5    Polan, M.L.6
  • 51
    • 0027934326 scopus 로고
    • Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1α and tumor necrosis factor-α
    • Rawdanowicz TJ, Hampton AL, Nagase H, et al. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 1994;79(2):530-536 (Pubitemid 24983154)
    • (1994) Journal of Clinical Endocrinology and Metabolism , vol.79 , Issue.2 , pp. 530-536
    • Rawdanowicz, T.J.1    Hampton, A.L.2    Nagase, H.3    Woolley, D.E.4    Salamonsen, L.A.5
  • 53
    • 0029153128 scopus 로고
    • Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium
    • Bruner KL, Rodgers WH, Gold LI, et al. Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995;92(16):7362-7366
    • (1995) Proc Natl Acad Sci USA , vol.92 , Issue.16 , pp. 7362-7366
    • Bruner, K.L.1    Rodgers, W.H.2    Gold, L.I.3
  • 54
    • 0027333411 scopus 로고
    • Tumor cell interactions with the extracellular matrix during invasion and metastasis
    • Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-573 (Pubitemid 2021155)
    • (1993) ANNU.REV.CELL BIOL. , vol.9 , pp. 541-573
    • Stetler-Stevenson, W.G.1    Aznavoorian, S.2    Liotta, L.A.3
  • 55
    • 34547103763 scopus 로고    scopus 로고
    • ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer
    • Monge M, Colas E, Doll A, et al. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer. Cancer Res 2007;67(14):6753-6759
    • (2007) Cancer Res , vol.67 , Issue.14 , pp. 6753-6759
    • Monge, M.1    Colas, E.2    Doll, A.3
  • 56
    • 0030478724 scopus 로고    scopus 로고
    • Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
    • DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO;2-7
    • Iwasaka C, Tanaka K, Abe M, et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996;169(3):522-531 (Pubitemid 26426918)
    • (1996) Journal of Cellular Physiology , vol.169 , Issue.3 , pp. 522-531
    • Iwasaka, C.1    Tanaka, K.2    Abe, M.3    Sato, Y.4
  • 57
    • 0028908322 scopus 로고
    • Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters
    • Higashino F, Yoshida K, Noumi T, et al. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 1995;10(7):1461-1463
    • (1995) Oncogene , vol.10 , Issue.7 , pp. 1461-1463
    • Higashino, F.1    Yoshida, K.2    Noumi, T.3
  • 58
    • 0025809504 scopus 로고
    • The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
    • Wasylyk C, Gutman A, Nicholson R, et al. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991;10(5):1127-1134 (Pubitemid 21905574)
    • (1991) EMBO Journal , vol.10 , Issue.5 , pp. 1127-1134
    • Wasylyk, C.1    Gutman, A.2    Nicholson, R.3    Wasylyk, B.4
  • 59
    • 0033757033 scopus 로고    scopus 로고
    • Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: Correlation to invasive potential
    • DOI 10.1006/gyno.2000.5944
    • Nishikawa A, Iwasaki M, Akutagawa N, et al. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Gynecol Oncol 2000;79(2):256-263 (Pubitemid 30822927)
    • (2000) Gynecologic Oncology , vol.79 , Issue.2 , pp. 256-263
    • Nishikawa, A.1    Iwasaki, M.2    Akutagawa, N.3    Manase, K.4    Yamashita, S.5    Endo, T.6    Kudo, R.7
  • 60
    • 0034936711 scopus 로고    scopus 로고
    • Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells
    • DOI 10.1006/gyno.2001.6229
    • Ueda M, Terai Y, Kumagai K, et al. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 2001;82(1):162-166 (Pubitemid 32634970)
    • (2001) Gynecologic Oncology , vol.82 , Issue.1 , pp. 162-166
    • Ueda, M.1    Terai, Y.2    Kumagai, K.3    Ueki, K.4    Yamaguchi, H.5    Akise, D.6    Ueki, M.7
  • 61
    • 1642578258 scopus 로고    scopus 로고
    • Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin
    • DOI 10.1080/09513590310001651740
    • Prifti S, Lelle I, Zhong G, et al. Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin. Gynecol Endocrinol 2004;18(1):23-27 (Pubitemid 38134760)
    • (2004) Gynecological Endocrinology , vol.18 , Issue.1 , pp. 23-27
    • Prifti, S.1    Lelle, I.2    Zhong, G.3    Strowitzki, T.4    Rabe, T.5
  • 62
    • 0030969129 scopus 로고    scopus 로고
    • Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation
    • Salamonsen LA, Butt AR, Hammond FR, et al. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997;82(5):1409-1415
    • (1997) J Clin Endocrinol Metab , vol.82 , Issue.5 , pp. 1409-1415
    • Salamonsen, L.A.1    Butt, A.R.2    Hammond, F.R.3
  • 63
    • 0030030666 scopus 로고    scopus 로고
    • Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle
    • Irwin JC, Kirk D, Gwatkin RB, et al. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996;97(2):438-447 (Pubitemid 26039408)
    • (1996) Journal of Clinical Investigation , vol.97 , Issue.2 , pp. 438-447
    • Irwin, J.C.1    Kirk, D.2    Gwatkin, R.B.L.3    Navre, M.4    Cannon, P.5    Giudice, L.C.6
  • 64
    • 0034824366 scopus 로고    scopus 로고
    • Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro
    • DOI 10.1006/gyno.2001.6294
    • Park DW, Ryu HS, Choi DS, et al. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro. Gynecol Oncol 2001;82(3):442-449 (Pubitemid 32826442)
    • (2001) Gynecologic Oncology , vol.82 , Issue.3 , pp. 442-449
    • Park, D.-W.1    Ryu, H.-S.2    Choi, D.-S.3    Park, Y.-H.4    Chang, K.-H.5    Min, C.K.6
  • 65
    • 3242756950 scopus 로고    scopus 로고
    • Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: Relationship to estrogen and progesterone receptor status
    • Cioppi F, Simi L, Luciani P, et al. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. Oncol Rep 2004;11(2):427-433
    • (2004) Oncol Rep , vol.11 , Issue.2 , pp. 427-433
    • Cioppi, F.1    Simi, L.2    Luciani, P.3
  • 66
    • 0036681322 scopus 로고    scopus 로고
    • Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells
    • Mizumoto H, Saito T, Ashihara K, et al. Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells. Int J Cancer 2002;100(4):401-406
    • (2002) Int J Cancer , vol.100 , Issue.4 , pp. 401-406
    • Mizumoto, H.1    Saito, T.2    Ashihara, K.3
  • 67
    • 2442649948 scopus 로고    scopus 로고
    • Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells
    • DOI 10.1016/j.canlet.2003.12.017, PII S0304383504000217
    • Saito T, Mizumoto H, Tanaka R, et al. Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells. Cancer Lett 2004;209(2):237-243 (Pubitemid 38670494)
    • (2004) Cancer Letters , vol.209 , Issue.2 , pp. 237-243
    • Saito, T.1    Mizumoto, H.2    Tanaka, R.3    Satohisa, S.4    Adachi, K.5    Horie, M.6    Kudo, R.7
  • 68
    • 0037222089 scopus 로고    scopus 로고
    • Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture
    • Park YH, Ryu HS, Choi DS, et al. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int J Gynecol Cancer 2003;13(1):53-60
    • (2003) Int J Gynecol Cancer , vol.13 , Issue.1 , pp. 53-60
    • Park, Y.H.1    Ryu, H.S.2    Choi, D.S.3
  • 71
    • 0022555838 scopus 로고
    • Biochemical interactions of tumor cells with the basement membrane
    • Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986;55:1037-1057 (Pubitemid 16070794)
    • (1986) Annual Review of Biochemistry , vol.VOL. 55 , pp. 1037-1057
    • Liotta, L.A.1    Rao, C.N.2    Wewer, U.M.3
  • 72
    • 0034472617 scopus 로고    scopus 로고
    • Matrix metalloproteinases in tumor invasion and metastasis
    • DOI 10.1006/scbi.2000.0379
    • Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10(6):415-433 (Pubitemid 32181912)
    • (2000) Seminars in Cancer Biology , vol.10 , Issue.6 , pp. 415-433
    • Stamenkovic, I.1
  • 73
    • 0034532365 scopus 로고    scopus 로고
    • Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential
    • DOI 10.1007/s004280000261
    • Mueller J, Brebeck B, Schmalfeldt B, et al. Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch 2000;437(6):618-624 (Pubitemid 32003092)
    • (2000) Virchows Archiv , vol.437 , Issue.6 , pp. 618-624
    • Mueller, J.1    Brebeck, B.2    Schmalfeldt, B.3    Kuhn, W.4    Graeff, H.5    Hofler, H.6
  • 77
    • 0036197006 scopus 로고    scopus 로고
    • Shed membrane fragment-associated markers for endometrial and ovarian cancers
    • DOI 10.1006/gyno.2001.6551
    • Taylor DD, Lyons KS, Gercel-Taylor C. Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol Oncol 2002;84(3):443-448 (Pubitemid 34211873)
    • (2002) Gynecologic Oncology , vol.84 , Issue.3 , pp. 443-448
    • Taylor, D.D.1    Lyons, K.S.2    Gercel-Taylor, C.3
  • 78
    • 41849105806 scopus 로고    scopus 로고
    • The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
    • Kenny HA, Kaur S, Coussens LM, et al. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008;118(4):1367-1379
    • (2008) J Clin Invest , vol.118 , Issue.4 , pp. 1367-1379
    • Kenny, H.A.1    Kaur, S.2    Coussens, L.M.3
  • 80
    • 49649098028 scopus 로고    scopus 로고
    • Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells
    • Cowden Dahl KD, Symowicz J, Ning Y, et al. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells. Cancer Res 2008;68(12):4606-4613
    • (2008) Cancer Res , vol.68 , Issue.12 , pp. 4606-4613
    • Cowden Dahl, K.D.1    Symowicz, J.2    Ning, Y.3
  • 81
    • 0036142697 scopus 로고    scopus 로고
    • Activated matrix metalloproteinase-2 - A potential marker of prognosis for epithelial ovarian cancer
    • DOI 10.1006/gyno.2001.6477
    • Wu X, Li H, Kang L, et al. Activated matrix metalloproteinase-2-a potential marker of prognosis for epithelial ovarian cancer. Gynecol Oncol 2002;84(1):126-134 (Pubitemid 34056478)
    • (2002) Gynecologic Oncology , vol.84 , Issue.1 , pp. 126-134
    • Wu, X.1    Li, H.2    Kang, L.3    Li, L.4    Wang, W.5    Shan, B.6
  • 82
    • 58149250998 scopus 로고    scopus 로고
    • Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer
    • Acar A, Onan A, Coskun U, et al. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med Oncol 2008;25(3):279-283
    • (2008) Med Oncol , vol.25 , Issue.3 , pp. 279-283
    • Acar, A.1    Onan, A.2    Coskun, U.3
  • 83
    • 58149483748 scopus 로고    scopus 로고
    • Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma
    • Adley BP, Gleason KJ, Yang XJ, et al. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol 2009;112(2):319-324
    • (2009) Gynecol Oncol , vol.112 , Issue.2 , pp. 319-324
    • Adley, B.P.1    Gleason, K.J.2    Yang, X.J.3
  • 85
    • 45949092504 scopus 로고    scopus 로고
    • Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1
    • DOI 10.1080/09513590802056995, PII 793697597
    • Liu B, Cai LY, Lv HM, et al. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol 2008;24(5):285-288 (Pubitemid 351891659)
    • (2008) Gynecological Endocrinology , vol.24 , Issue.5 , pp. 285-288
    • Liu, B.1    Cai, L.-Y.2    Lv, H.-M.3    Xia, L.4    Zhang, Y.-J.5    Zhang, H.-X.6    Guan, Y.-M.7
  • 87
    • 0031909775 scopus 로고    scopus 로고
    • MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts
    • DOI 10.1016/S0046-8177(98)90226-X
    • Afzal S, Lalani EN, Poulsom R, et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998;29(2):155-165 (Pubitemid 28099511)
    • (1998) Human Pathology , vol.29 , Issue.2 , pp. 155-165
    • Afzal, S.1    Lalani, E.-N.2    Poulsom, R.3    Stubbs, A.4    Rowlinson, G.5    Sato, H.6    Seiki, M.7    Stamp, G.W.H.8
  • 88
    • 59049090760 scopus 로고    scopus 로고
    • Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2
    • Brun JL, Cortez A, Commo F, et al. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Int J Oncol 2008;33(6):1239-1246
    • (2008) Int J Oncol , vol.33 , Issue.6 , pp. 1239-1246
    • Brun, J.L.1    Cortez, A.2    Commo, F.3
  • 95
  • 97
    • 15244350530 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: Relationship with prognosis
    • Ahmed MI, Salahy EE, Tawfiq H, et al. Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: relationship with prognosis. Dis Markers 2004;20(6):333-343 (Pubitemid 40385314)
    • (2004) Disease Markers , vol.20 , Issue.6 , pp. 333-343
    • Ahmed, M.I.1    Salahy, E.-E.2    Tawfiq, H.3    Khalifa, A.4    Hassan, M.M.5
  • 98
    • 0033019235 scopus 로고    scopus 로고
    • MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
    • DOI 10.1006/gyno.1999.5381
    • Davidson B, Goldberg I, Kopolovic J, et al. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 1999;73(3):372-382 (Pubitemid 29272858)
    • (1999) Gynecologic Oncology , vol.73 , Issue.3 , pp. 372-382
    • Davidson, B.1    Goldberg, I.2    Kopolovic, J.3    Lerner-Geva, L.4    Gotlieb, W.H.5    Ben-Baruch, G.6    Reich, R.7
  • 99
    • 0036500250 scopus 로고    scopus 로고
    • Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion
    • DOI 10.1002/cncr.10355
    • Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002;94(5):1466-1475 •• An outstanding paper on MMPs in endometrial carcinoma. (Pubitemid 34213290)
    • (2002) Cancer , vol.94 , Issue.5 , pp. 1466-1475
    • Di Nezza, L.A.1    Misajon, A.2    Zhang, J.3    Jobling, T.4    Quinn, M.A.5    Ostor, A.G.6    Nie, G.7    Lopata, A.8    Salamonsen, L.A.9
  • 100
    • 0038703340 scopus 로고    scopus 로고
    • MT1-MMP and MMP-7 in invasion and metastasis of human cancers
    • DOI 10.1023/A:1023039230052
    • Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003;22(2-3):145-152 (Pubitemid 36561054)
    • (2003) Cancer and Metastasis Reviews , vol.22 , Issue.2-3 , pp. 145-152
    • Shiomi, T.1    Okada, Y.2
  • 103
    • 33749152996 scopus 로고    scopus 로고
    • Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions
    • DOI 10.1111/j.1525-1438.2006.00717.x
    • Graesslin O, Cortez A, Uzan C, et al. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 2006;16(5):1911-1917 (Pubitemid 44470055)
    • (2006) International Journal of Gynecological Cancer , vol.16 , Issue.5 , pp. 1911-1917
    • Graesslin, O.1    Cortez, A.2    Uzan, C.3    Birembaut, P.4    Quereux, C.5    Darai, E.6
  • 106
    • 0042123774 scopus 로고    scopus 로고
    • Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity
    • DOI 10.1016/S0090-8258(03)00328-7
    • Lopata A, Agresta F, Quinn MA, et al. Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity. Gynecol Oncol 2003;90(2):318-324 (Pubitemid 36952020)
    • (2003) Gynecologic Oncology , vol.90 , Issue.2 , pp. 318-324
    • Lopata, A.1    Agresta, F.2    Quinn, M.A.3    Smith, C.4    Ostor, A.G.5    Salamonsen, L.A.6
  • 107
    • 0029738845 scopus 로고    scopus 로고
    • Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer
    • Mutter GL, Boynton KA, Faquin WC, et al. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res 1996;56(19):4483-4486
    • (1996) Cancer Res , vol.56 , Issue.19 , pp. 4483-4486
    • Mutter, G.L.1    Boynton, K.A.2    Faquin, W.C.3
  • 108
    • 0032774472 scopus 로고    scopus 로고
    • Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer
    • Moser PL, Hefler L, Tempfer C, et al. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Anticancer Res 1999;19(3B):2365-2367 (Pubitemid 29392548)
    • (1999) Anticancer Research , vol.19 , Issue.3 B , pp. 2365-2367
    • Moser, P.L.1    Hefler, L.2    Tempfer, C.3    Neunteufel, W.4    Kieback, D.G.5    Gitsch, G.6
  • 110
    • 34447505972 scopus 로고    scopus 로고
    • Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma
    • DOI 10.1016/j.prp.2007.03.008, PII S0344033807000817
    • Yang X, Dong Y, Zhao J, et al. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. Pathol Res Pract 2007;203(7):499-505 (Pubitemid 47065354)
    • (2007) Pathology Research and Practice , vol.203 , Issue.7 , pp. 499-505
    • Yang, X.1    Dong, Y.2    Zhao, J.3    Sun, H.4    Deng, Y.5    Fan, J.6    Yan, Q.7
  • 111
    • 0033595649 scopus 로고    scopus 로고
    • Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
    • Ueno H, Yamashita K, Azumano I, et al. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer 1999;84(5):470-477
    • (1999) Int J Cancer , vol.84 , Issue.5 , pp. 470-477
    • Ueno, H.1    Yamashita, K.2    Azumano, I.3
  • 112
    • 33644692295 scopus 로고    scopus 로고
    • Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis
    • Misugi F, Sumi T, Okamoto E, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Int J Mol Med 2005;16(4):541-546
    • (2005) Int J Mol Med , vol.16 , Issue.4 , pp. 541-546
    • Misugi, F.1    Sumi, T.2    Okamoto, E.3
  • 113
    • 0028650295 scopus 로고
    • Matrix metalloproteinase gene expression
    • Matrisian LM. Matrix metalloproteinase gene expression. Ann NY Acad Sci 1994;732:42-50
    • (1994) Ann NY Acad Sci , vol.732 , pp. 42-50
    • Matrisian, L.M.1
  • 114
    • 49649096620 scopus 로고    scopus 로고
    • MMP-2, TIMP-1, E-cadherin, and β-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium
    • Shaco-Levy R, Sharabi S, Piura B, et al. MMP-2, TIMP-1, E-cadherin, and β-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium. Acta Obstet Gynecol Scand 2008;87(8):868-874
    • (2008) Acta Obstet Gynecol Scand , vol.87 , Issue.8 , pp. 868-874
    • Shaco-Levy, R.1    Sharabi, S.2    Piura, B.3
  • 115
    • 55749084920 scopus 로고    scopus 로고
    • High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma
    • Honkavuori M, Talvensaari-Mattila A, Puistola U, et al. High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma. Anticancer Res 2008;28(5A):2715-2719
    • (2008) Anticancer Res , vol.28 , Issue.5 A , pp. 2715-2719
    • Honkavuori, M.1    Talvensaari-Mattila, A.2    Puistola, U.3
  • 117
    • 43049121273 scopus 로고    scopus 로고
    • Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps
    • Erdemoglu E, Guney M, Karahan N, et al. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas 2008;59(3):268-274
    • (2008) Maturitas , vol.59 , Issue.3 , pp. 268-274
    • Erdemoglu, E.1    Guney, M.2    Karahan, N.3
  • 119
    • 0034283015 scopus 로고    scopus 로고
    • Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
    • Uria JA, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 2000;60(17):4745-4751 (Pubitemid 30701482)
    • (2000) Cancer Research , vol.60 , Issue.17 , pp. 4745-4751
    • Uria, J.A.1    Lopez-Otin, C.2
  • 120
    • 0034686076 scopus 로고    scopus 로고
    • Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme
    • DOI 10.1074/jbc.275.20.14809
    • Stracke JO, Hutton M, Stewart M, et al. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 2000;275(20):14809- 14816 (Pubitemid 30337192)
    • (2000) Journal of Biological Chemistry , vol.275 , Issue.20 , pp. 14809-14816
    • Stracke, J.O.1    Hutton, M.2    Stewart, M.3    Pendas, A.M.4    Smith, B.5    Lopez-Otin, C.6    Murphy, G.7    Knauper, V.8
  • 121
    • 0036309737 scopus 로고    scopus 로고
    • Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3
    • Zhang J, Cao YJ, Zhao YG, et al. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod 2002;8(7):659-666 (Pubitemid 34752927)
    • (2002) Molecular Human Reproduction , vol.8 , Issue.7 , pp. 659-666
    • Zhang, J.1    Cao, Y.-J.2    Zhao, Y.-G.3    Sang, Q.-X.A.4    Duan, E.-K.5
  • 122
    • 0028827415 scopus 로고
    • Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form
    • Tamakoshi K, Kikkawa F, Nawa A, et al. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 1995;76(12):2565-2571
    • (1995) Cancer , vol.76 , Issue.12 , pp. 2565-2571
    • Tamakoshi, K.1    Kikkawa, F.2    Nawa, A.3
  • 123
    • 0031228307 scopus 로고    scopus 로고
    • Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle
    • Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod 1997;3(9):735-741
    • (1997) Mol Hum Reprod , vol.3 , Issue.9 , pp. 735-741
    • Zhang, J.1    Salamonsen, L.A.2
  • 124
    • 0027407101 scopus 로고
    • Stability analysis of latent and active 72-kDa type IV collagenase: The role of tissue inhibitor of metalloproteinases-2 (TIMP-2)
    • Kleiner DE Jr, Tuuttila A, Tryggvason K, et al. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 1993;32(6):1583-1592 (Pubitemid 23077567)
    • (1993) Biochemistry , vol.32 , Issue.6 , pp. 1583-1592
    • Kleiner Jr., D.E.1    Tuuttila, A.2    Tryggvason, K.3    Stetler-Stevenson, W.G.4
  • 125
    • 0033966536 scopus 로고    scopus 로고
    • Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium
    • Zhang J, Hampton AL, Nie G, et al. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000;62(1):85-94 (Pubitemid 30013472)
    • (2000) Biology of Reproduction , vol.62 , Issue.1 , pp. 85-94
    • Zhang, J.1    Hampton, A.L.2    Nie, G.3    Salamonsen, L.A.4
  • 128
    • 28044458735 scopus 로고    scopus 로고
    • Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor
    • Rauvala M, Puistola U, Turpeenniemi-Hujanen T. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor. Gynecol Oncol 2005;99(3):656-663
    • (2005) Gynecol Oncol , vol.99 , Issue.3 , pp. 656-663
    • Rauvala, M.1    Puistola, U.2    Turpeenniemi-Hujanen, T.3
  • 129
    • 33845948559 scopus 로고    scopus 로고
    • The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer
    • Rauvala M, Turpeenniemi-Hujanen T, Puistola U. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer. Anticancer Res 2006;26(6C):4779-4784 (Pubitemid 46032113)
    • (2006) Anticancer Research , vol.26 , Issue.6 C , pp. 4779-4784
    • Rauvala, M.1    Turpeenniemi-Hujanen, T.2    Puistola, U.3
  • 130
    • 0034279752 scopus 로고    scopus 로고
    • Prognostic value of serum MMP-2 level in uterine cancer affected women
    • Adamiak A, Postawski K, Semczuk A, et al. Prognostic value of serum MMP-2 level in uterine cancer affected women. Ginekol Pol 2000;71(9):1198-1201
    • (2000) Ginekol Pol , vol.71 , Issue.9 , pp. 1198-1201
    • Adamiak, A.1    Postawski, K.2    Semczuk, A.3
  • 131
    • 0042624791 scopus 로고    scopus 로고
    • Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies
    • DOI 10.1016/S0090-8258(03)00334-2
    • Bazzett LB, Magnus M, Taylor DD, et al. Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies. Gynecol Oncol 2003;90(2):435-442 (Pubitemid 36952041)
    • (2003) Gynecologic Oncology , vol.90 , Issue.2 , pp. 435-442
    • Bazzett, L.B.1    Magnus, M.2    Taylor, D.D.3    Gercel-Taylor, C.4
  • 132
    • 0034122601 scopus 로고    scopus 로고
    • Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
    • Sier CF, Casetta G, Verheijen JH, et al. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers. Clin Cancer Res 2000;6(6):2333-2340 (Pubitemid 30399200)
    • (2000) Clinical Cancer Research , vol.6 , Issue.6 , pp. 2333-2340
    • Sier, C.F.M.1    Casetta, G.2    Verheijen, J.H.3    Tizzani, A.4    Agape, V.5    Kos, J.6    Blasi, F.7    Hanemaaijer, R.8
  • 133
    • 0035318082 scopus 로고    scopus 로고
    • Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma
    • Gerhards S, Jung K, Koenig F, et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001;57(4):675-679
    • (2001) Urology , vol.57 , Issue.4 , pp. 675-679
    • Gerhards, S.1    Jung, K.2    Koenig, F.3
  • 134
    • 0030723230 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibitors: Present achievements and future prospects
    • DOI 10.1023/A:1005855905442
    • Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs 1997;15(3):175-185 (Pubitemid 27453872)
    • (1997) Investigational New Drugs , vol.15 , Issue.3 , pp. 175-185
    • Denis, L.J.1    Verweij, J.2
  • 135
    • 0029188425 scopus 로고
    • Matrix metalloproteinase inhibitors: A novel class of anticancer agents
    • Brown PD. Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv Enzyme Regul 1995;35:293-301
    • (1995) Adv Enzyme Regul , vol.35 , pp. 293-301
    • Brown, P.D.1
  • 136
    • 31344458952 scopus 로고    scopus 로고
    • Structure and function of matrix metalloproteinases and TIMPs
    • DOI 10.1016/j.cardiores.2005.12.002, PII S0008636305005651
    • Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69(3):562-573 (Pubitemid 43139720)
    • (2006) Cardiovascular Research , vol.69 , Issue.3 , pp. 562-573
    • Nagase, H.1    Visse, R.2    Murphy, G.3
  • 137
    • 0030609810 scopus 로고    scopus 로고
    • 1.8-Å crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile
    • Betz M, Huxley P, Davies SJ, et al. 1.8-Å crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile. Eur J Biochem 1997;247(1):356-363 (Pubitemid 27319524)
    • (1997) European Journal of Biochemistry , vol.247 , Issue.1 , pp. 356-363
    • Betz, M.1    Huxley, P.2    Davies, S.J.3    Mushtaq, Y.4    Pieper, M.5    Tschesche, H.6    Bode, W.7    Gomis-Ruth, E.X.8
  • 138
    • 0035819527 scopus 로고    scopus 로고
    • Development of matrix metalloproteinase inhibitors in cancer therapy
    • Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93(3):178-193 • An informative review about MMPIs and cancer therapy. (Pubitemid 32166488)
    • (2001) Journal of the National Cancer Institute , vol.93 , Issue.3 , pp. 178-193
    • Hidalgo, M.1    Eckhardt, S.G.2
  • 139
    • 34250630512 scopus 로고    scopus 로고
    • A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas
    • DOI 10.1007/s10637-006-9031-6
    • Chu QS, Forouzesh B, Syed S, et al. A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas. Invest New Drugs 2007;25(4):359-367 (Pubitemid 46944843)
    • (2007) Investigational New Drugs , vol.25 , Issue.4 , pp. 359-367
    • Chu, Q.S.C.1    Forouzesh, B.2    Syed, S.3    Mita, M.4    Schwartz, G.5    Copper, J.6    Curtright, J.7    Rowinsky, E.K.8
  • 140
    • 0032983844 scopus 로고    scopus 로고
    • Marimastat (BB2516): Current status of development
    • Steward WP. Marimastat (BB2516): current status of development. Cancer Chemother Pharmacol 1999;43(Suppl):S56-60
    • (1999) Cancer Chemother Pharmacol , vol.43 , Issue.SUPPL.
    • Steward, W.P.1
  • 141
    • 0037348721 scopus 로고    scopus 로고
    • A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of mmp-expressing tumor cells in nude mice
    • DOI 10.1002/ijc.10875
    • Yamamoto A, Yano S, Shiraga M, et al. A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice. Int J Cancer 2003;103(6):822-828 (Pubitemid 36110241)
    • (2003) International Journal of Cancer , vol.103 , Issue.6 , pp. 822-828
    • Yamamoto, A.1    Yano, S.2    Shiraga, M.3    Ogawa, H.4    Goto, H.5    Miki, T.6    Zhang, H.7    Sone, S.8
  • 142
    • 0032612382 scopus 로고    scopus 로고
    • New drugs on the horizon: Matrix metalloproteinase inhibitors
    • Rothenberg ML, Nelson AR, Hande KR. New drugs on the horizon: matrix metalloproteinase inhibitors. Stem Cells 1999;17(4):237-240
    • (1999) Stem Cells , vol.17 , Issue.4 , pp. 237-240
    • Rothenberg, M.L.1    Nelson, A.R.2    Hande, K.R.3
  • 143
    • 0033034041 scopus 로고    scopus 로고
    • Clinical studies with matrix metalloproteinase inhibitors
    • Brown PD. Clinical studies with matrix metalloproteinase inhibitors. APMIS 1999;107(1):174-180 (Pubitemid 29133538)
    • (1999) APMIS , vol.107 , Issue.1 , pp. 174-180
    • Brown, P.D.1
  • 145
    • 0032837028 scopus 로고    scopus 로고
    • Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
    • DOI 10.1111/j.1749-6632.1999.tb07689.x
    • Shalinsky DR, Brekken J, Zou H, et al. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci 1999;878:236-270 (Pubitemid 29353575)
    • (1999) Annals of the New York Academy of Sciences , vol.878 , pp. 236-270
    • Shalinsky, D.R.1    Brekken, J.2    Zou, H.3    McDermott, C.D.4    Forsyth, P.5    Edwards, D.6
  • 148
    • 0027251836 scopus 로고
    • A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
    • Davies B, Brown PD, East N, et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53(9):2087-2091 (Pubitemid 23145731)
    • (1993) Cancer Research , vol.53 , Issue.9 , pp. 2087-2091
    • Davies, B.1    Brown, P.D.2    East, N.3    Crimmin, M.J.4    Balkwill, F.R.5
  • 150
    • 0031848158 scopus 로고    scopus 로고
    • Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites
    • Beattie GJ, Smyth JF. Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res 1998;4(8):1899-1902
    • (1998) Clin Cancer Res , vol.4 , Issue.8 , pp. 1899-1902
    • Beattie, G.J.1    Smyth, J.F.2
  • 151
    • 0030855863 scopus 로고    scopus 로고
    • Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: Enhancement of effect by batimastat
    • DOI 10.1016/S0959-8049(97)88065-3, PII S0959804997000877
    • Burke F, East N, Upton C, et al. Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 1997;33(7):1114-1121 (Pubitemid 27310785)
    • (1997) European Journal of Cancer Part a , vol.33 , Issue.7 , pp. 1114-1121
    • Burke, F.1    East, N.2    Upton, C.3    Patel, K.4    Balkwill, F.R.5
  • 152
    • 0141482154 scopus 로고    scopus 로고
    • Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation
    • Belotti D, Paganoni P, Manenti L, et al. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 2003;63(17):5224-5229 (Pubitemid 37139832)
    • (2003) Cancer Research , vol.63 , Issue.17 , pp. 5224-5229
    • Belotti, D.1    Paganoni, P.2    Manenti, L.3    Garofalo, A.4    Marchini, S.5    Taraboletti, G.6    Giavazzi, R.7
  • 154
    • 0026499369 scopus 로고
    • Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo
    • Khokha R, Zimmer MJ, Wilson SM, et al. Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 1992;10(6):365-370
    • (1992) Clin Exp Metastasis , vol.10 , Issue.6 , pp. 365-370
    • Khokha, R.1    Zimmer, M.J.2    Wilson, S.M.3
  • 155
    • 0033044209 scopus 로고    scopus 로고
    • The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells
    • DOI 10.1023/A:1026438801080
    • Erba E, Ronzoni S, Bassano L, et al. The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells. Ann Oncol 1999;10(5):589-591 (Pubitemid 29305438)
    • (1999) Annals of Oncology , vol.10 , Issue.5 , pp. 589-591
    • Erba, E.1    Ronzoni, S.2    Bassano, L.3    Giavazzi, R.4    D'Incalci, M.5
  • 161
    • 0034722898 scopus 로고    scopus 로고
    • Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
    • DOI 10.1038/sj.onc.1204097
    • Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19(56):6642-6650 (Pubitemid 32197703)
    • (2000) Oncogene , vol.19 , Issue.56 , pp. 6642-6650
    • Zucker, S.1    Cao, J.2    Chen, W.-T.3
  • 162
    • 37349082926 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
    • A well written article about MMPs and their inhibitors
    • Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75(2):346-359 •• A well written article about MMPs and their inhibitors.
    • (2008) Biochem Pharmacol , vol.75 , Issue.2 , pp. 346-359
    • Raffetto, J.D.1    Khalil, R.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.